Epithelial Paradox: Clinical Significance of Coexpression of E-cadherin and Vimentin With Regard to Invasion and Metastasis of Breast Cancer

被引:68
|
作者
Yamashita, Nami [1 ]
Tokunaga, Eriko [3 ]
Iimori, Makoto [2 ]
Inoue, Yuka [1 ]
Tanaka, Kimihiro [1 ]
Kitao, Hiroyuki [2 ]
Saeki, Hiroshi [1 ]
Oki, Eiji [1 ]
Maehara, Yoshihiko [1 ]
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka, Fukuoka, Japan
[2] Kyushu Univ, Grad Sch Med Sci, Dept Mol Oncol, Fukuoka, Fukuoka, Japan
[3] Natl Hosp Org, Dept Breast Oncol, Kyushu Canc Ctr, Fukuoka, Fukuoka, Japan
关键词
Aggressive; Collective invasion; EMT; Metastatic lymph nodes; Partial EMT; MESENCHYMAL TRANSITION; CELL INVASION; PANCREATIC-CANCER; EXPRESSION; CARCINOMAS; MECHANISMS; MIGRATION; PATHOGENESIS; PLASTICITY; SLUG;
D O I
10.1016/j.clbc.2018.02.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
E-cadherin and vimentin are regarded as major conventional canonical markers of epithelial-mesenchymal transition. Both E-cadherine- and vimentin-positive tumors had the worst prognosis among all cases. Further, E-cadherin and vimentin protein is colocalized within the same tumor cells, suggesting the existence of an aggressive subpopulation in the primary tumor nest of breast cancer. Background: E-cadherin and vimentin are regarded as major conventional canonical markers of the epithelial-mesenchymal transition. It is commonly assumed that E-cadherin is uniformly lost during the process of epithelial-mesenchymal transition. Breast tumor cells typically invade as a cohesive multicellular unit in a process called collective invasion. The aim of this study was to reveal the clinical importance of the expression pattern of E-cadherin and vimentin in breast cancer. Methods: E-cadherin and vimentin protein expression was evaluated by immunohistochemistry in 176 invasive breast cancer samples. Among these, E-cadherin and vimentin expression were evaluated in the set of primary site and metastatic lymph nodes in 65 cases. In addition, E-cadherin and vimentin expression were analyzed by confocal laser scanning microscopy to see E-cadherin and vimentin localization in the breast cancer cells. Results: Both at the primary site and metastatic lymph nodes, both E-cadherine and vimentin-positive tumors had the worst disease-free and overall survival among all cases. In addition, E-cadherin and vimentin protein is colocalized within the same tumor cells in a human breast cancer specimen. Conclusion: Our present data suggest the existence of an aggressive subpopulation in the primary tumor nest of breast cancer. (C) 2018 Elsevier Inc. All rights reserved.
引用
收藏
页码:E1003 / E1009
页数:7
相关论文
共 50 条
  • [31] E-cadherin deregulation in breast cancer
    Corso, Giovanni
    Figueiredo, Joana
    De Angelis, Simone Pietro
    Corso, Federica
    Girardi, Antonia
    Pereira, Joana
    Seruca, Raquel
    Bonanni, Bernardo
    Carneiro, Patricia
    Pravettoni, Gabriella
    Guerini Rocco, Elena
    Veronesi, Paolo
    Montagna, Giacomo
    Sacchini, Virgilio
    Gandini, Sara
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2020, 24 (11) : 5930 - 5936
  • [32] LOBULAR BREAST CANCER AND E-CADHERIN
    Blair, Vanessa
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2013, 9 : 85 - 85
  • [33] Expression of E-cadherin and α-catenin in patients with colorectal carcinoma -: Correlation with cancer invasion and metastasis
    Gofuku, J
    Shiozaki, H
    Tsujinaka, T
    Inoue, M
    Tamura, S
    Doki, Y
    Matsui, S
    Tsukita, S
    Kikkawa, N
    Monden, M
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1999, 111 (01) : 29 - 37
  • [34] E-Cadherin Induces Serine Synthesis to Support Progression and Metastasis of Breast Cancer
    Lee, Geonhui
    Wong, Claudia
    Cho, Anna
    West, Junior J.
    Crawford, Ashleigh J.
    Russo, Gabriella C.
    Si, Bishwa R.
    Kim, Jungwoo
    Hoffner, Lauren
    Jang, Cholsoon
    Jung, Moonjung
    Leone, Robert D.
    Konstantopoulos, Konstantinos
    Ewald, Andrew J.
    Wirtz, Denis
    Jeong, Sangmoo
    CANCER RESEARCH, 2024, 84 (17) : 2820 - 2835
  • [35] MRNA AND PROTEIN EXPRESSION OF E-CADHERIN AND VIMENTIN AND P53 IMMUNOHISTOCHEMISTRY IN EPITHELIAL OVARIAN CANCER
    Rajaram, S.
    Chaudhary, S.
    Banerjee, B. D.
    Arora, V. K.
    Gupta, B.
    Garg, P. K.
    Jain, S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A134 - A134
  • [36] Expressions and clinical significance of CCN5 and E-cadherin in primary and recurrent lesions of breast cancer
    Zhou, Guofeng
    Gui, Xingxing
    Qu, Wei
    Zhang, Xiujuan
    FRONTIERS IN GENETICS, 2024, 15
  • [37] E-Cadherin fragments as potential mediators for peritoneal metastasis in advanced epithelial ovarian cancer
    Fabian Trillsch
    Sascha Kuerti
    Christine Eulenburg
    Eike Burandt
    Linn Woelber
    Katharina Prieske
    Kathrin Eylmann
    Leticia Oliveira-Ferrer
    Karin Milde-Langosch
    Sven Mahner
    British Journal of Cancer, 2016, 114 : 213 - 220
  • [38] E-Cadherin fragments as potential mediators for peritoneal metastasis in advanced epithelial ovarian cancer
    Trillsch, Fabian
    Kuerti, Sascha
    Eulenburg, Christine
    Burandt, Eike
    Woelber, Linn
    Prieske, Katharina
    Eylmann, Kathrin
    Oliveira-Ferrer, Leticia
    Milde-Langosch, Karin
    Mahner, Sven
    BRITISH JOURNAL OF CANCER, 2016, 114 (02) : 213 - 220
  • [39] E-CADHERIN FRAGMENTS AS POTENTIAL MEDIATORS FOR PERITONEAL METASTASIS IN ADVANCED EPITHELIAL OVARIAN CANCER
    Trillsch, F.
    Kuerti, S.
    Eulenburg, C.
    Burandt, E.
    Woelber, L.
    Prieske, K.
    Eylmann, K.
    Oliveira-Ferrer, L.
    Milde-Langosch, K.
    Mahner, S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 1516 - 1517
  • [40] Loss of E-cadherin is not a necessity for epithelial to mesenchymal transition in human breast cancer
    Antoinette Hollestelle
    Justine K. Peeters
    Marcel Smid
    Mieke Timmermans
    Leon C. Verhoog
    Pieter J. Westenend
    Anouk A. J. Heine
    Alan Chan
    Anieta M. Sieuwerts
    Erik A. C. Wiemer
    Jan G. M. Klijn
    Peter J. van der Spek
    John A. Foekens
    Mieke Schutte
    Michael A. den Bakker
    John W. M. Martens
    Breast Cancer Research and Treatment, 2013, 138 : 47 - 57